Cresco Labs, Inc. (CRLBF)
0.6438
+0.01
(+1.23%)
USD |
OTCM |
Oct 09, 16:00
Cresco Labs Net Income (Quarterly) : 15.37M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.37M |
| March 31, 2026 | -17.01M |
| December 31, 2025 | -88.95M |
| September 30, 2025 | -21.97M |
| June 30, 2025 | -13.89M |
| March 31, 2025 | -15.23M |
| December 31, 2024 | 0.439M |
| September 30, 2024 | -7.694M |
| June 30, 2024 | -51.18M |
| March 31, 2024 | -2.055M |
| December 31, 2023 | 4.868M |
| September 30, 2023 | -113.44M |
| June 30, 2023 | -43.46M |
| March 31, 2023 | -27.81M |
| December 31, 2022 | -180.62M |
| September 30, 2022 | -3.249M |
| June 30, 2022 | -8.296M |
| March 31, 2022 | -23.68M |
| December 31, 2021 | -11.91M |
| September 30, 2021 | -263.45M |
| June 30, 2021 | 2.653M |
| March 31, 2021 | -24.12M |
| December 31, 2020 | -41.19M |
| September 30, 2020 | 25.58M |
| June 30, 2020 | -41.70M |
| Date | Value |
|---|---|
| March 31, 2020 | -35.46M |
| December 31, 2019 | -45.22M |
| September 30, 2019 | -8.594M |
| June 30, 2019 | -3.918M |
| March 31, 2019 | -7.574M |
| December 31, 2018 | -2.606M |
| January 31, 2018 | -0.0394M |
| October 31, 2017 | -0.0135M |
| July 31, 2017 | -0.0156M |
| April 30, 2017 | -0.0135M |
| January 31, 2017 | -0.0659M |
| October 31, 2016 | -0.0083M |
| July 31, 2016 | -0.0185M |
| April 30, 2016 | -0.0143M |
| January 31, 2016 | -0.0247M |
| October 31, 2015 | -0.0111M |
| July 31, 2015 | 0.1044M |
| April 30, 2015 | -0.0197M |
| January 31, 2015 | -0.0636M |
| October 31, 2014 | -0.0305M |
| July 31, 2014 | -0.0263M |
| April 30, 2014 | -0.018M |
| January 31, 2014 | -0.0887M |
| October 31, 2013 | -0.0622M |
| July 31, 2013 | -0.0398M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| cbdMD, Inc. | -1.127M |
| Trulieve Cannabis Corp. | -405.36M |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 173.34M |
| Total Expenses (Quarterly) | 156.54M |
| EPS Diluted (Quarterly) | 0.0356 |
| Enterprise Value | 672.28M |
| Gross Profit Margin (Quarterly) | 46.49% |
| Profit Margin (Quarterly) | 8.87% |
| Earnings Yield | -45.29% |
| Operating Earnings Yield | 34.93% |
| Normalized Earnings Yield | -4.349 |